03.06.2014 • NewsDNA sequencingGenia TechnologiesIllumina

Roche Acquires DNA Sequencing Firm

Swiss pharmaceutical producer Roche has announced plans to buy privately held US gene-sequencing firm Genia Technologies for up to $350 million, securing access to a technology that should allow it to decipher human genes more quickly at a cheaper cost.

Under the deal, Genia's shareholders will receive $125 million in cash and up to $225 million in contingent payments depending on certain milestones.

Dan Zabrowski, head of Roche's sequencing unit, said the new technology had the potential to be more accurate, faster and less expensive than existing systems.

While most systems currently on the market make copies of DNA in order to generate enough coherent data to be read by the sequencing platform, he said Genia's technology, however, is based on the measurement of single DNA molecules and thus reduces the amount of errors and information.

Other sequencing platforms also rely on expensive optical sensors, but Genia uses cheap electronic semiconductors, the same as those used in cell phones and computers, to measure changes in electrical currents and identify DNA sequences.

Zabrowski said Roche is still on the lookout for external partnering opportunities in sequencing as well as developing its offering in-house.

In 2012, the Swiss company abandoned an attempt to buy gene-sequencing company Illumina for $6.7 billion after the US firm's shareholders held out for a higher price.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

most read